Free Trial
CVE:SCYB

Scythian Biosciences (SCYB) Stock Price, News & Analysis

C$3.49
-0.22 (-5.93%)
(As of 07/25/2018)

About Scythian Biosciences Stock (CVE:SCYB)

Key Stats

Today's Range
C$3.46
C$3.77
50-Day Range
C$3.49
C$3.49
52-Week Range
C$1.01
C$8.61
Volume
703,164 shs
Average Volume
231,491 shs
Market Capitalization
C$102.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Scythian Biosciences Corp. engages in the research and development of cannabinoid-based combination drug therapies for the treatment of concussions and traumatic brain injury. It also develops drug candidates for the treatment of gastro-intestinal inflammatory issues. The company is headquartered in Toronto, Canada.

Receive SCYB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Scythian Biosciences and its competitors with MarketBeat's FREE daily newsletter.

SCYB Stock News Headlines

Scryb Inc. (SCYRF)
Schwab High Yield Bond ETF (SCYB)
Banking failure dead ahead
If you missed it, my emergency election broadcast is now available - but will be removed soon
Scryb Inc SCYB
Scryb Inc. (SCYB.CN)
Ventrus Biosciences (VTUS) Stock Surges Today
Canadian Jobs to be Presented Next Friday
See More Headlines

SCYB Stock Analysis - Frequently Asked Questions

Scythian Biosciences' stock was trading at C$3.49 at the beginning of the year. Since then, SCYB stock has increased by 0.0% and is now trading at C$3.49.
View the best growth stocks for 2024 here
.

Shares of SCYB stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Scythian Biosciences investors own include DraftKings (DKNG), Lithium South Development Co. (NGZ.V) (NGZ), Organigram (OGI), Scythian Biosciences (SCCYF), SOL Global Investments (SOLCF), CanniMed Therapeutics (CMED) and Compugen (CGEN).

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
C$102.38 million
Optionable
Not Optionable
Beta
N/A
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (CVE:SCYB) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners